Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
Mudter
J
J
Laboratory of Immunology, First Medical Clinic, University of Mainz, 55131 Mainz, Germany. mudter@uni-mainz.de
Neurath
M F
MF
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D017209:Apoptosis / Q000276:immunology*; D001379:Azathioprine / Q000627:therapeutic use; D002470:Cell Survival / Q000276:immunology; D003424:Crohn Disease / Q000209:etiology / Q000276:immunology / Q000628:therapy; D006801:Humans; D018928:Immunity, Mucosal / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology; D018664:Interleukin-12 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D007413:Intestinal Mucosa / Q000276:immunology; D019804:Mesalamine / Q000627:therapeutic use; D015398:Signal Transduction / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12; D019804:Mesalamine; D001379:Azathioprine